Jiro Tadokoro

Prognostic impact of <i>CEBPA</i> bZIP domain mutation in acute myeloid leukemia

Satoshi Wakita, Masahiro Sakaguchi, Iekuni Oh et al. · Blood Advances · 2021 · 118 citations · Full text

Medicine, Hematology, Molecular Biology +11

Low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) for previously treated patients with relapsed or primary resistant acute myelogenous leukemia (AML) and previously untreated elderly patients with AML, secondary AML, and refractory anemia with excess blasts in transformation.

Kenji Saito, Y Nakamura, Mitsuo Aoyagi et al. · PubMed · 2000 · 72 citations

Medicine, Hematology, Pharmacology +17

Mutational analysis of <i>DNMT3A</i> improves the prognostic stratification of patients with acute myeloid leukemia

Satoshi Wakita, Atsushi Marumo, Kaoru Morita et al. · Cancer Science · 2023 · 26 citations · Full text

Medicine, Molecular Genetics, Oncology +17